| Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants D Kerjaschki, N Huttary, I Raab, H Regele, K Bojarski-Nagy, G Bartel, ... Nature medicine 12 (2), 230-234, 2006 | 438 | 2006 |
| A randomized trial of bortezomib in late antibody-mediated kidney transplant rejection F Eskandary, H Regele, L Baumann, G Bond, N Kozakowski, ... Journal of the American Society of Nephrology 29 (2), 591-605, 2018 | 250 | 2018 |
| Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse D Kerjaschki, Z Bago-Horvath, M Rudas, V Sexl, C Schneckenleithner, ... The Journal of clinical investigation 121 (5), 2000-2012, 2011 | 197 | 2011 |
| Building kidney exchange programmes in Europe—an overview of exchange practice and activities P Biró, B Haase-Kromwijk, T Andersson, EI Ásgeirsson, T Baltesová, ... Transplantation 103 (7), 1514-1522, 2019 | 128 | 2019 |
| A randomized clinical trial of anti–IL-6 antibody clazakizumab in late antibody-mediated kidney transplant rejection K Doberer, M Duerr, PF Halloran, F Eskandary, K Budde, H Regele, ... Journal of the American Society of Nephrology 32 (3), 708-722, 2021 | 120 | 2021 |
| Comparison of SARS-CoV-2 antibody response 4 weeks after homologous vs heterologous third vaccine dose in kidney transplant recipients: a randomized clinical trial R Reindl-Schwaighofer, A Heinzel, M Mayrdorfer, R Jabbour, ... JAMA internal medicine 182 (2), 165-171, 2022 | 111 | 2022 |
| Complement component C3 activation: the leading cause of the prozone phenomenon affecting HLA antibody detection on single-antigen beads E Schwaiger, M Wahrmann, G Bond, F Eskandary, GA Böhmig Transplantation 97 (12), 1279-1285, 2014 | 111 | 2014 |
| Quantification of torque teno virus viremia as a prospective biomarker for infectious disease in kidney allograft recipients R Strassl, M Schiemann, K Doberer, I Görzer, E Puchhammer-Stöckl, ... The Journal of infectious diseases 218 (8), 1191-1199, 2018 | 107 | 2018 |
| Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation G Bartel, M Wahrmann, H Regele, ® Kikić, G Fischer, W Druml, ... American Journal of Transplantation 10 (9), 2033-2042, 2010 | 102 | 2010 |
| Torque Teno virus load—inverse association with antibody-mediated rejection after kidney transplantation M Schiemann, E Puchhammer-Stöckl, F Eskandary, P Kohlbeck, ... Transplantation 101 (2), 360-367, 2017 | 98 | 2017 |
| Prevention and treatment of alloantibody‐mediated kidney transplant rejection G Bartel, E Schwaiger, GA Böhmig Transplant International 24 (12), 1142-1155, 2011 | 82 | 2011 |
| Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients—a prospective observational trial K Doberer, M Schiemann, R Strassl, F Haupenthal, F Dermuth, I Görzer, ... American Journal of Transplantation 20 (8), 2081-2090, 2020 | 81 | 2020 |
| Posttransplant HLA alloreactivity in stable kidney transplant recipients—incidences and impact on long-term allograft outcomes G Bartel, H Regele, M Wahrmann, N Huttary, M Exner, WH Hörl, ... American Journal of Transplantation 8 (12), 2652-2660, 2008 | 81 | 2008 |
| Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection E Schwaiger, F Eskandary, N Kozakowski, G Bond, ® Kikić, D Yoo, ... Nephrology Dialysis Transplantation 31 (8), 1342-1351, 2016 | 79 | 2016 |
| Clinical relevance of preformed C4d‐fixing and non‐C4d‐fixing HLA single antigen reactivity in renal allograft recipients M Wahrmann, G Bartel, M Exner, H Regele, GF Körmöczi, GF Fischer, ... Transplant International 22 (10), 982-989, 2009 | 79 | 2009 |
| In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts G Bartel, M Wahrmann, M Exner, H Regele, N Huttary, M Schillinger, ... American Journal of Transplantation 8 (1), 41-49, 2008 | 78 | 2008 |
| Diagnostic contribution of donor-specific antibody characteristics to uncover late silent antibody-mediated rejection—results of a cross-sectional screening study F Eskandary, G Bond, N Kozakowski, H Regele, L Marinova, ... Transplantation 101 (3), 631-641, 2017 | 72 | 2017 |
| Determinants of the complement-fixing ability of recipient presensitization against HLA antigens G Bartel, M Wahrmann, M Exner, H Regele, M Schillinger, WH Hörl, ... Transplantation 83 (6), 727-733, 2007 | 71 | 2007 |
| CD38 antibody daratumumab for the treatment of chronic active antibody-mediated kidney allograft rejection K Doberer, J Kläger, GA Gualdoni, KA Mayer, F Eskandary, EA Farkash, ... Transplantation 105 (2), 451-457, 2021 | 66 | 2021 |
| Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial F Eskandary, M Dürr, K Budde, K Doberer, R Reindl-Schwaighofer, ... Trials 20, 1-13, 2019 | 62 | 2019 |
Zeljko KikicE-mail megerősítve itt: meduniwien.ac.at
